4//SEC Filing
Thaler Bjorn B 4
Accession 0001562180-22-007756
CIK 0001404123other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 8:37 PM ET
Size
15.5 KB
Accession
0001562180-22-007756
Insider Transaction Report
Form 4
Thaler Bjorn B
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-11-15−10,251→ 30,752 total→ Common Stock (10,251 underlying) - Exercise/Conversion
Common Stock
2022-11-15+10,251→ 24,730 total - Sale
Common Stock
2022-11-16$16.81/sh−3,935$66,142→ 20,795 total - Sale
Common Stock
2022-11-17$16.70/sh−761$12,709→ 20,034 total
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis.
- [F2]Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F3]This transaction was executed in multiple trades at prices ranging from $16.80 to $16.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing.
- [F5]The restricted stock units will vest annually over three years, with 25% of the restricted stock units vesting on each of the first and second anniversaries of the vesting commencement date and 50% of the restricted stock units vesting on the third anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date.
Issuer
1Life Healthcare Inc
CIK 0001404123
Entity typeother
Related Parties
1- filerCIK 0001800588
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 8:37 PM ET
- Size
- 15.5 KB